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Distal filtration versus flow reversal: An ex vivo
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Pauline M. Velez, MD, Linda M. Reilly, MD, Jade Hiramoto, MD, and Xian-Mang Pan, MD, San
Francisco, Calif
Objectives: Choices for embolic protection during carotid stent procedures include distal filtration (DF) and proximal
occlusion with flow reversal (POFR). DF devices are widely used but have produced only modest improvements in clinical
outcomes. There is less experience with POFR devices but single center reports suggest reduced emboli detected by
transcranial Doppler (TCD). To determine if POFR offers a significant improvement in embolic protection, we tested five
DF devices and two POFR devices with 8F and 10F sheath design in an ex vivo angioplasty system using human carotid
plaques excised en bloc. Physiologic pressures and flows were used and the efficiency of plaque fragment removal by these
devices compared.
Methods: Thirty-three human carotid plaques removed en bloc were secured in tailored polytetrafluoroethylene (PTFE)
grafts. The distal PTFE was either 6 mm or 5 mm inner diameter (ID). Saline was delivered through the excised carotid
plaque as follows: a cleaning 50 mL flush was done prior to the angioplasty procedure and discarded; further flushes of
forward flow were done with five pressurized “pulsations” of 10 mL each (50 mL), peak pressure 140 mm Hg. Balloon
angioplasty was done with a 4 mm and then a 6 mm balloon. DF flushes were applied after each angioplasty and
“postprocedure” after the device was removed. With POFR, 50 mL were collected through the sheath after balloon
angioplasty by either back-pressure of 20mmHg, 40mmHg or 60mmHg, or by aspiration. Postangioplasty pressurized
forward flush of 50 or 100 mL was done as described. Each flush was collected, centrifuged, and examined for plaque
fragments. Fragments greater than 60 microns were sized and counted on a 100 micron grid.
Results:When DF devices were used in 6 mm lumen PTFE, the percent of fragments trapped was poor (13.7% to 27.8%).
There were no statistically significant differences between the devices. The capture of fragments improved (22% vs 51.4%,
P < .001) when devices appropriate for a 6 mm lumen were used in a 5 mm PTFE “ICA”, functionally over-sizing the
devices. POFR efficiency improved with increasing back-pressures and with repeated aspirations. Postprocedure,
successive flushes of pressurized forward flow yielded additional plaque fragments and when the efficiency of POFR was
assessed with forward flushing volumes similar to those used for DF, the efficiencies were similar, although larger
fragments were more efficiently removed with POFR.
Conclusion: In our model, both protection strategies were less than ideal. For POFR, high back pressures or multiple
aspirations improve the efficiency of cerebral protection but additional fragments were released by pressurized flow even
after aspiration of 150 mL of saline. DF devices create a pressure gradient and fragments apparently went around the
device with pressurized flow in our PTFE lumen. Over-sizing of DF devices partially corrected this problem and increased
over all DF efficiency to be comparable to POFR for smaller fragments but not for larger fragments. ( J Vasc Surg 2009;
49:1181-8.)The advanced carotid plaque, a localized, bulky ather-
oma that contains a soft necrotic core and a thin fibrous cap
prone to ulceration, promotes the formation of emboli.
Carotid stenosis is the only major vascular lesion that
primarily causes ischemia by distal embolization. Not sur-
prisingly, both in vivo and ex vivo studies have shown that
hundreds to tens of thousands of plaque fragments are
created when angioplasty and stenting are applied to these
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tolerance for microembolization and stroke rates are low,
these high rates of emboli are concerning for both carotid
stenting and for the open surgical alternative, endarterec-
tomy. Microemboli detected by transcranial Doppler
(TCD) are associated with accelerated cognitive decline in
humans.6,7 In animals, embolization of cholesterol crystals
causes impaired cognition8 associated with prolonged acti-
vation of microglia, an observation associated with im-
paired cognition in other models.9,10 Various strategies
have been developed to prevent embolization during an-
gioplasty and stenting, of which the most commonly em-
ployed is distal filtration (DF).
DF may reduce but certainly does not eliminate cere-
bral emboli. Several reports including the “lead in” data
from Carotid Revascularization Endarterectomy Versus
Stenting Trial (CREST) have shown a reduction in central
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es,11,12 but others have not.13,14 With DF devices in place,
TCD detected a mean of over 600 total solid emboli in the
intracranial circulation with bursts following both angio-
plasty and stent deployment.4 Other studies with TCD
have suggested that rather than reducing it, embolization
may actually increase with the use of distal filtration devic-
es.15,16 They claim devicemanipulation through the plaque
prior to deployment and trauma to the distal internal
carotid artery (ICA) wall may create more emboli than are
entrapped within the device. The clinical data conflict with
ex vivo testing of DF devices reporting high rates of cap-
ture.17,18 These models used constant flow. Device behav-
ior could be quite different in pulsatile flow. DF creates a
pressure gradient 19 that reduces flow velocity in the distal
ICA20 and conditions of high pressure and flow may allow
increased flow through or around the device.
Proximal occlusion with retrograde flow (PORF)
offers an alternate strategy to DF. To achieve complete
occlusion, both the external and common carotid arter-
ies are blocked. Fragment removal is then provided by
back flow through the introducing sheath from either
ICA “stump” pressure or aspiration. This approach elim-
inates unprotected crossing of the lesion and trauma to
the distal carotid.4,21 Compared with DF, there are
reports of fewer emboli detected by TCD22 and fewer
lesions postprocedure by diffusion-weighted magnetic
resonance imaging (DWMRI),23 but clinical results com-
paring DF and POFR have been mixed.14,24
Neither of these protection strategies has been tested ex
vivo with pressurized “pulsatile” flow conditions that
would simulate in vivo carotid angioplasty. To determine
the relative effectiveness of DF and POFR under conditions
that simulate pulsatile flow, we have tested the relative
protection afforded by various devices in an ex vivo model
of carotid plaque angioplasty. The efficiency of each device
in preventing embolization of plaque fragments greater
than 60 microns was determined.
METHODS
Carotid plaques (Fig)
Thirty-three carotid endarterectomy specimens were
excised en bloc, ie, only the adventitia was incised and
plaque from the distal CCA, proximal ECA and ICA were
removed without cutting longitudinally into the lumen.
They were then washed in saline and stored in a sodium
azide solution at 20°C. To allow minimally traumatic wire
cannulation of the specimen, a 6-0 silk suture was placed
through the lumen from the CCA to the ICA in all speci-
mens and for those specimens in which the MoMa device
(Invatec, Roncadelle, Italy) was to be tested, a second silk
suture was placed through the external carotid lumen. The
plaques were then placed in PTFE “adventitia” sleeves
using a thin coat of Super Glue (cyanoacrylate; Super Glue
Corp., Rancho Cucamonga, Calif). PTFEwas tailored to fit
the specimens with 8 or 10 mm PTFE used to create the
“CCA” and either 6 mm or 5 mm grafts used to create the“ICA”. The PTFE grafts extended approximately 6 cm
beyond the plaque both proximally and distally. The grafts
were sutured with prolene suture and super glue was ap-
plied to the suture lines to ensure that they were water-
tight.
General protocol
Whether DF or POFR devices were to be tested, the
PFTE tube containing the plaque was secured proximally
to an 8F sheath or 10F for the MoMa experiments. To
simulate pulsatile flow, hand injections were done with 10
mL per flush generating pressures of 140mmHg. Pressures
were measured using a pressure gauge attached to a side
arm. For the POFR and MoMa procedures, back-pressure
was applied to the distal PTFE. This was removed prior to
flushing as all forward flushing was collected from the distal
end of the PTFE.
Distal filtration
The Angioguard (Cordis Corporation, Warren, NJ),
Accunet (Abbott Laboratories, Abbott Park, Ill), Em-
boshield (Abbott laboratories, Abbott Park, Ill), Filterwire
EZ (Boston Scientific, Natick, Mass), and Spider (ev3 Inc.,
Plymouth, Minn) were tested in our system. For these
experiments, the external carotid plaque was sutured closed
and sealed with super glue. The 0.014 filter wire was passed
using the 6-0 silk suture previously placed in through the
plaque lumen. Once the wire and filtration device were
guided through the lesion, the proximal PFTE was sealed
around an 8F sheath and flushed with 50mL to remove any
plaque fragments created during plaque preparation. After
this flush, the filtration device was deployed in the distal
PFTE. Plaque angioplasty was performed with a 4 mm and
then a 6 mm balloon. Saline (50 mL) was flushed through
the PTFE and collected after each angioplasty as noted
above. The device was retrieved per manufacturers’ instruc-
Fig. Carotid plaques excised en bloc were placed in tailored
polytetrafluoroethylene (PTFE) “adventitia”. The 6-0 silk suture
was used to direct the guide wires through the plaque lumen.tions and a final pulsatile flush (50 mL) was done for a total
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mL of saline and rinsed repeatedly to remove all particu-
lates.
Proximal occlusion with reversal of flow
In these experiments, the two styles of devices required
slightly different preparations.
Parodi antiembolism system (PAES). Our model of
the proximal occlusion device was patterned after the
PAES.Occlusion of the external carotid artery is required in
the PAES, and the external carotid artery was occluded for
these experiments. Instead of a balloon, which is part of the
actual PAES, we used an 8 mm diameter plastic cylinder 15
mm in length with an 8F sheath placed in the center of the
cylinder so that the tip was level with the cylinder surface.
Prior to placing this apparatus in the proximal PTFE, a
0.014 wire was advanced through the sheath and pulled
through the ICA plaque using the 6-0 silk suture traversing
the plaque lumen. Once in place, umbilical tape was tied
around the cylinder to secure it in place.
MoMa proximal occlusion device preparation. A
10F MoMa proximal occlusion device was used in these
experiments. Like the PAES, the MoMa is designed to
balloon occlude both the external carotid and the common
carotid artery. To place the external carotid balloon, a 6-0
silk suture was used to pull a 0.035 angled glide wire
through the external carotid lumen. A similar process was
used to place a 0.014 wire through the ICA plaque into the
distal PTFE. Both wires were then back loaded into the
MoMa device. The distal balloon (ECA) was not inflated
but the external carotid artery plaque was ligated around
the device just proximal to the balloon. The device was
oriented so that the sheath lumen was facing the plaque
ICA and the device’s proximal occluding balloon was in-
flated to 2 mm Hg.
Procedures. For both devices, once the 0.014 wire
was in place and the PTFE proximal to the plaque oc-
cluded, the plaque was forward flushed with 50 mL of
saline out the distal PTFE “ICA” to remove any plaque
fragments generated with the wire manipulations prior to
angioplasty as with the clearing flush for DF; this was not
analyzed. The angioplasty procedure was then performed as
noted.
Collections of saline were obtained by two methods.
When back flow was used, 50 mL of saline was delivered
through the PTFE distal to the plaque and collected from
the device sheath after each angioplasty (100 mL). Back
flow was created using a reservoir of saline that was 20 mm
Hg, 40 mm Hg or 60 mm Hg above the procedure table.
When aspiration was to be done, saline was aspirated
though the sheath in 50 mL portions after the angioplasty
procedures were completed. For these procedures the sa-
line reservoir was at 20 mm Hg. No passive flow was
allowed.
All collections of saline were analyzed for plaque frag-
ments as outlined below.Angioplasty
Both 4 mm and 6 mm balloon angioplasties were done
on each specimen by advancing the balloons over the 0.014
wire and rapidly inflating the balloons to 15 atmospheres
and then rapid balloon deflation.
Pulsatile forward flow
Each forward flush was done with a series of five
“pulses” done by hand injection with a peak pressure of 140
mm Hg measured via a pressure gauge connected with a
“y” port to the tubing. Each “pulse” contained 10 mL of
saline for a total of 50cc. Because there was a discrepancy
between the volumes of flush for the DF (150 mL) and
POFR experiments (50 mL), in a separate series of three
experiments a second forward flush was done to determine
if additional fragments would be dislodged.
Counting of plaque fragments
Each saline collection was centrifuged for 20 minutes,
the supernatant decanted, and the pellet resuspended.
Fragments greater than 60 microns were counted under
50 magnification.
Statistical analysis
A 2 analysis was used to examine the differences be-
tween the trapping of fragments in 6 mm and 5 mm distal
“ICA” lumens and between the fragments collected by DF
and POFR.
RESULTS
Numbers of plaque fragments released with ex vivo
angioplasty
As we found in previous experience with this tech-
nique,3 the number of fragments created by angioplasty
varied among the plaques tested. The amount of variation
covered two orders of magnitude, from hundreds to tens of
thousands. This is reflected in the substantial standard
deviation of our results. Generally, plaques that released a
greater number of small fragments also released a greater
number of large fragments. All plaques produced fragments
that were 1 mm or larger.
Performance of distal filtration devices
The distal filtration devices tested were appropriate for
deployment in a 6 mm vessel per manufacturers’ recom-
mendations. The efficiency of DF device capture in a 6 mm
PTFE lumenwas poor ranging from 13.7% to 27.8% (Table
I). There was no appreciable difference in the capture
efficiency of small (99 micron) or large (1 mm) frag-
ments.
Given the relatively poor performance of the distal
filtration devices across all fragment sizes, we postulated
that a large portion of saline was flowing around rather than
through the device. We then examined the efficiency of
these devices in a 5 mm PTFE lumen, functionally over-
sizing the device (Table II). There was significant improve-
ment in all size categories so that the total capture increased
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came from an increased capture of fragments less than 99
microns.
Proximal occlusion devices
Forward flush with 50 cc postprocedure. After an-
gioplasty with both the 4mm and 6mmballoons, 50mL of
Table I. Percent carotid plaque fragments caught by dista
[60 - 99
microns]
[100 to 199
microns]
Average SD Average SD A
Spider n  3
Angioplasty 423.3 210.0 131.3 27.0
Flush 206.7 127.0 62.3 37.0
Caught 113.0 100.0 28.7 29.0
% Caught 15.2% 12.9%
Emboshield n  2
Angioplasty 221.5 84.1 103.5 57.3
Flush 117.0 106.1 49.0 46.7
Caught 158.5 79.9 57.5 53.0
% Caught 31.9% 27.4%
Angioguard n  3
Angioplasty 305.3 154.5 99.0 28.9
Flush 168.7 125.1 79.3 69.8
Caught 160.0 70.8 67.3 66.0
% Caught 25.2% 27.4%
Filter wire n  2
Angioplasty 945.7 958.1 346.5 367.0
Flush 616.5 539.5 110.5 74.2
Caught 521.5 505.6 150.0 134.4
% Caught 25.0% 24.7%
Accunet n  1
Angioplasty 368.0 N 200.0 N
Flush 64.0 N 29.0 N
Caught 136.0 N 80.0 N
% Caught 23.9% 25.9%
Angioplasty: Fragments post 4 mm and 6 mm angioplasty not caught by di
Flush: Fragments retrieved from pressurized flow post procedure (distal filt
Caught: Fragments captured in the distal filtration devices.
Table II. Percent carotid plaque fragments caught by dist
60-99 microns 100-199 microns 20
Average SD Average SD Av
Experiments using a 6 mm lumen (n  1)
Angioplasty 445 416 163 152
Flush 242 270 70 51
Caught 210 231 71 70
% Caught 23.5% 23.4%
Experiments using a 5 mm lumen (n  6)
Angioplasty 952 466 262 69
Flush 385 199 93 61
Caught 1,889 1,325 182 170
% Caught 58.6% 33.9%
Angioplasty: Fragments post 4 mm and 6 mm angioplasty not caught by di
Flush: Fragments retrieved from pressurized flow post procedure (distal filt
Trapped: Fragments caught in the distal filtration devices.saline was collected with 20 mm Hg of back pressure. Thiscontained material 60.4% of fragments when only a single
flush of 50 mL was done postprocedure (Table III). With a
back-pressure of 40 mmHg this increased to 72.7%. There
was minimal further increase in recovery by increasing the
back-pressure to 60 mm Hg.
When aspiration was used to remove fragments, we
found a single aspiration of 50 mL with POFR was compa-
ration devices after angioplasty
0 to 499
icrons]
[500 - 999
microns, 1 mm] 1 mm
Totalge SD Average SD Average SD
22.0 65.7 43.0 13.0 9.0 742.3
32.0 37.0 26.0 9.7 6.0 370.7
13.0 11.3 7.0 5.0 1.0 177.3
0.5% 9.9% 18.1% 13.7%
31.1 54.0 1.4 6.5 2.1 471.5
12.7 18.0 9.9 4.5 4.9 226.5
13.4 20.0 4.2 7.0 2.8 268.5
7.1% 21.7% 38.9% 27.8%
83.5 109.3 109.8 22.0 18.2 664.3
86.2 86.3 92.1 23.3 20.8 459.6
35.8 25.0 14.0 4.3 1.2 310.8
9.0% 11.3% 8.7% 21.7%
52.2 112.0 52.3 21.5 4.9 1635.7
36.1 53.0 9.9 12.7 9.9 913.2
106.8 52.5 67.2 28.0 35.4 848.5
2.6% 24.1% 45.0% 25.0%
N 70.0 N 24.0 N 787.0
N 16.0 N 5.0 N 147.0
N 19.0 N 6.0 N 301.0
7.5% 18.1% 17.1% 24.4%
tration devices during pressurized flow.
device removed).
eration devices in a 6 mm vs 5 mm lumon
microns
500-999
microns 1 mm
TotalSD Average SD Average SD
61 84 61 17 11 839
55 48 51 14 13 448
48 25 27 9 15 364
.9% 15.8% 23.7% 22.0%
107 86 58 21 8 1,509
65 49 34 12 5 632
115 57 48 16 5 2,263
.9% 29.5% 32.2% 51.4%
tration devices during pressurized flow.
device removed).l filte
[20
m
vera
109.0
55.0
19.3
1
86.0
38.0
25.5
1
128.7
102.0
54.0
1
210.0
120.5
96.5
2
125.0
33.0
60.0
2
stal fil
rational filt
0-499
erage
130
75
48
18
188
93
119
29
stal fil
rationrable to 20 mm Hg back-pressure (Table IV). When re-
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bled with a second aspiration and increased by
approximately 10% with a third aspiration (Table V). Com-
bining the three aspirations gave a yield that was compara-
Table III. Carotid plaque fragments from angioplasty: Re
with an 8F sheath
60-99
microns
100-199
microns
Average SD Average SD A
20 mm Hg n  3
Back flow 832 432 273 204
Flush (50 mL) 487 150 207 106
Protection (%) 63.1% 56.9%
40 mm Hg n  3
Back flow 457 13 126 75
Flush (50 mL) 151 64 48 28
Protection (%) 75.2% 72.4%
60 mm Hg n  3
Back flow 355 110 94 14
Flush (50 mL) 106 27 29 15
Protection (%) 77.0% 76.4%
Flush: Forward flow with pressurized pulsations.
Table IV. Carotid plaque fragments from angioplasty: Re
device with a MOMA or 8F sheath device
60-99
microns
100-199
microns
Average SD Average SD A
MOMA n  2
Aspiration 136 152 11 10
Forward 170 233 22 21
Protection % 44.4% 33.3%
8F n  3
Aspiration 168 163 45 28
Forward 149 94 35 17
Protection % 53.0% 56.3%
Note: forward Flush consists of 50 mL.
Table V. Carotid plaque fragments captured by increasing
60-99 micron 100-199 micron 2
Average SD Average SD A
MOMA n  2
1st 50 mL 60 69 3 1
2nd 50 mL 68 85 6 7
3rd 50 mL 9 1 2 2
Forward 170 233 22 21
Protection % 44.6% 33.3%
8F n  3
1st 50 mL 117 133 27 19
2nd 50 mL 38 28 12 8
3rd 50 mL 13 11 6 1
Forward Flush 149 94 38 17
Protection % 53.0% 54.2%
Forward flush consists of 50 mL of pressurized flow.ble to that achieved with the higher back-pressures.Pressurized flush postprocedure. The relatively
small amount of additional material retrieved after the third
aspiration of 50 mL saline, suggested that there were
relatively few fragments remaining. However, when pres-
al with back flow through a proximal occlusion device
0-499
icrons
500-999
microns 1 mm
Totale SD Average SD Average SD
63 52 27 15 3 1319
52 45 12 14 4 864
7.0% 53.6% 51.7% 60.4%
31 45 6 15 2 739
24 25 14 7 2 278
7.1% 64.3% 68.2% 72.7%
22 40 11 13 8 572
23 18 15 7 7 189
0.1% 69.0% 65.0% 75.2%
l with a single aspiration through a proximal occlusion
-499
crons
500-999
microns 1 mm
Totale SD Average SD Average SD
3 12 2 6 4 179
13 7 9 4 4 225
.9% 63.2% 60.0% 44.3%
20 16 8 7 4 275
24 15 22 5 8 237
.2% 51.6% 58.3% 53.7%
iration volumes in POFR devices
99 micron 500-999 micron 1 mm
Totalge SD Average SD Average SD
5 8 1 3 3 79
8 3 1 3 1 86
0 1 0 0 0 13
13 7 9 4 4 225
8.9% 63.2% 60.0% 44.2%
12 4 7 4 4 181
16 10 4 2 2 91
3 2 2 1 1 25
24 16 22 5 8 244
2.0% 50.0% 58.3% 54.9%mov
20
m
verag
147
111
5
96
47
6
70
29
7mova
200
mi
verag
14
22
38
39
33
54asp
00-4
vera
7
6
1
22
3
7
29
3
36
5surized flow was reintroduced into the system a substantial
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mine if the plaque would continue to release additional
fragments with pressurized flow, we applied a second
flush of 50 mL of saline and increased our yield of
fragments not retrieved by POFR by an additional 20%
to 30% (Table VI). Assuming a third flush, as was done in
the DF experiments, would yield yet additional frag-
ments, we used the conservative factor of 0.25 times the
fragment number in the first flush to estimate the actual
protection afforded by the POFR devices. This gave a
mean of 44.4% and was not significantly different than
DF when over-sized devices were used. However, the
removal of fragments greater than 100 microns was
numerically greater using the POFR devices (P  ns).
DISCUSSION
Compression of atherosclerotic plaque by balloon an-
gioplasty fractures the plaque’s integrity and has been
shown2,3,25 to create hundreds to tens of thousands of
plaque fragments. Various techniques have been used to
limit the embolization of these fragments, the leading ones
being DF and POFR. While both are commercially avail-
able outside the United States, only DF devices are cur-
rently approved in the United States. Clinical investigations
suggest that POFR devices are more effective at reducing
emboli during carotid angioplasty and stenting22,23 al-
though clinical outcomes may,24 or may not,14 be im-
proved. Reports on ex vivo testing of DF and POFR
suggest a high level of effectiveness but these models did
not include pressurized flow nor did they demonstrate
device effectiveness across the full spectrum of plaque frag-
ment sizes.
In our model, when DF devices were sized to the
lumen as per manufactures recommendations, they trapped
only 22% of fragments released. Although there was a range
of efficiency among the devices, the experimental variation
suggests that there were very little real differences between
them. The most disturbing finding was the inability of the
DF devices to consistently trap plaque fragments larger
than the filter pore size, an observation also made in vivo by
TCD.4 Given that each of these devices creates a pressure
gradient,19,20 we postulated that with pressurized flow,
saline was flowing around the filter. Reducing the size of
the PTFE lumen in our system dramatically improved the
over-all performance of the DF devices, but significant
numbers of larger sized particles still evaded capture. Fur-
ther over-sizing of the devices or reducing the pulse pres-
sure may further improve the performance of these devices
Table VI. Fragments by repeated post procedure flush, n
60-99 micron 100-199 micron 20
Average SD Average SD Av
1st 50 mL 171 113 27 16
2nd 50 mL 44 34 8 6but these options were not examined.We initially tested POFR with a passive back flow
system after each angioplasty (100 mL total). A back-
pressure of 20 mm Hg from the distal PTFE “ICA” gave a
reasonable rate of fragment removal particularly for larger
fragment sizes. There was a higher percent removal with
increasing back-pressure although the improvement from
40mmHg to 60 mmHg was minimal. Direct comparisons
with DF could not be made as the forward flush with these
experiments were done with only 50 mL. Current recom-
mendations for use of the MoMa and PAES do not call for
passive flow from back-pressure but suggest “at least” a 50
mL aspiration through the system. A single aspiration of 50
mL did not appear to be adequate in our system. However,
when the aspirations were repeated times two so that the
total volume removed was the same as with the back-
pressure experiments (150 mL), the efficiency was similar.
The ability to perform repeated aspirations then filter and
then return the blood to the patient will be an important
design feature of these devices.
The yield with the third aspiration of 50 mL was low
suggesting that few fragments remained. However, apply-
ing pressurized flow to the plaque released hundreds of
fragments and a second flush yielded evenmore. Determin-
ing the true efficiency of these devices requires knowing the
total number of fragments available. Unfortunately, this is
not possible. Given this observation, we can only estimate
the true fraction of plaque fragments removed by POFR to
be approximately 44%. Over-all protection was not signifi-
cantly different for POFRwith aspiration than for DF when
the DF devices were over-sized.
Like other ex vivo models, ours had some important
differences from in vivo carotid angioplasty (CAS) which
could have affected our results. We had no accounting for
the plaque fragments released with placement of the pro-
tection devices. This can be substantial15 and could reduce
the effectiveness of the DF devices further. Several factors
could have increased the number of fragments created in
our model. Carotid plaques removed, placed in saline, and
refrigerated may have fragmented more easily than plaques
in vivo. In addition, PTFE is less compliant than adventitia
and this, plus our high pressure angioplasty, may have
caused the release of larger numbers of fragments com-
pared to in vivo. We used saline in our system and the lower
viscosity could have increased (or decreased) the observed
leakage around the DF devices. It should be noted that
similar ineffectiveness of DF has been shown in vivo with
hundreds of HITS recorded on TCD during carotid angio-
plasty while DF devices were in place.4,16 As the lower limit
9 micron 500-999 micron 1 mm
TotalSD Average SD Average SD
11 6 7 2 2 227
1 1 1 1 2 59 2
0-49
erage
21of emboli detection by TCD is approximately 80 microns,
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We did not include data on fragments smaller than 60
microns since only fragments 60-100 microns are clearly
implicated in cognitive decline.8 Smaller fragments may be
biologically significant, as animal data suggests that micro-
spheres with diameters of 15 microns are caught in the
cerebrovascular microcirculation.26 Finally, we did not
stent the plaque and our yield of fragments with the appli-
cation of pulsatile flow postprocedure may be greater than
if the plaque were stented. On the other hand, both ex
vivo3 and in vivo4,16 data indicate that stenting releases as
many fragments as angioplasty; it seems likely this would
increase, not decrease, the number of fragments released.
Furthermore, TCD data clearly shows that there is continu-
ing release of fragments postprocedure as the stented
plaque is subjected to pulsatile flow.26
Our data indicates that any of the approaches, POFR
devices with either high back pressures or multiple aspira-
tions, and over-sized DF devices will reduce, but not elim-
inate the number of emboli reaching the brain during CAS.
While any reduction is laudable, there is certainly room for
improvement. Furthermore, postprocedure when the pro-
tection device was either removed or not functional, our
data shows that with pressurized forward flow the fractured
plaque continued to shed fragments. Late emboli have
been documented in vivo by TCD26 and by DW-MRI27
performed days after the procedure. The majority (77%) of
neurologic events with CAS occur postprocedure with 20%
occurring post discharge.28 If carotid angioplasty and
stenting is to be pursued as treatment for carotid stenosis,
reducing the total embolic load released to the brain must
be the priority. Not only to reduce clinical neurologic
events but also to limit the subtle subclinical damage to
which microemboli may contribute.
This material is based upon work supported (or sup-
ported in part) by the Department of Veterans Affairs,
Veteren’s Health Administration, Office of Research and
Development.
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